lifestyle.jardal-paintball.com

Author: DBV Technologies S.A.

DBV Technologies Reports First Quarter 2026 Financial Results

April 30, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026

April 2, 2026
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document

March 26, 2026
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

March 24, 2026
DBV Technologies to Participate in Upcoming March Investor Conferences

March 4, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026

March 3, 2026
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting

February 28, 2026
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting

February 13, 2026
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit

February 12, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026

February 11, 2026